Abstract:Objective To investigate the effect of low-frequency ultrasound on the release of vancomycin from antibiotic-loaded bone cement (ALBC) and its regularity in vitro and in vivo. Methods ALBC specimens were successfully manufactured for in vitro and in vivo assays. 5% and 10% ALBC specimens were both randomly divided into three groups: the control group, 100 mW/cm2 ultrasound group and 300 mW/cm2 ultrasound group. After immersing in PBS of 40 ml for 8 h, the four ultrasound groups were exposed to a timed local ultrasonic field for 30 min, then the drug cumulative concentrations were observed during a 2.5 h period after exposure and on the 24th hour after immersion. Sixteen healthy New Zealand white rabbits were divided randomly into two groups: the ultrasound group was exposed to a local timed intermittent ultrasound field and the control group not. Samples of drainage fluid and urine were collected at programmed intervals during a 5 d period, and the ALBC specimens were extracted from rabbits four weeks after implantations with all their concentrations measured by fluorescence polarization immunoassay (FPIA). Results After immersing 24 h in vitro, the cumulative concentration of vancomycin additionally increased by 71.77% and 73.62% in 10% 100 mW/cm2 ultrasound group and 300 mW/cm2 group respectively comparing with 10% control group; while increased 13.03% and 23.78% in 5% 100 mW/cm2 and 300 mW/cm2 groups comparing with 5% control group. Furthermore, the total release was positively correlated with the ultrasound intensity (P 0.05) and the amount of vancomycin loaded in specimens (P 0.01). The total release of vancomycin increased by 148.18% (P 0.01) and 82.39% (P 0.05) in 7.5% specimens during a 1 d period and a 5 d period in vivo, respectively, caused by intermittent 30 min exposures of ultrasound with an intensity of 300 mW/cm2. More decreased residue of vancomycin was detected in the ultrasound group than in the control group four weeks after implantations (P 0.01). Conclusion Low-frequency low-intensity continuous ultrasound may provide an effective method to enhance and accelerate the vancomycin release of ALBC.

Ultrasound-degradable Serum Albumin Nanoplatform Forin Situcontrolled Drug Release

One-pot Synthesis of Hollow PDA@DOX Nanoparticles for Ultrasound Imaging and Chemo-Thermal Therapy in Breast Cancer

Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release

A Novel Strategy to Fabricate Doxorubicin/bovine Serum Albumin/porous Silicon Nanocomposites with Ph-Triggered Drug Delivery for Cancer Therapy in Vitro.

Stimuli-responsive Biodegradable Poly(methacrylic Acid) Based Nanocapsules for Ultrasound Traced and Triggered Drug Delivery System.

In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes

Multifunctional Bovine Serum Albumin-Based Nanocarriers with Endosomal Escaping and NIR Light-Controlled Release to Overcome Multidrug Resistance of Breast Cancer Cells

Effect of Ultrasound on Drug Release of Vancomycin-Loaded Acrylic Bone Cement

PEGylated denatured bovine serum albumin modified water-soluble inorganic nanocrystals as multifunctional drug delivery platforms

Continuous Processing of Phase-Change Materials into Uniform Nanoparticles for Near-Infrared-triggered Drug Release

Engineered stealth porous silicon nanoparticles via surface encapsulation of bovine serum albumin for prolonging blood circulation in vivo.

Ultrasound-actuated drug delivery with acoustic percolation switches

Preparation and Characterization of Sodium Ferulate Entrapped Bovine Serum Albumin Nanoparticles for Liver Targeting

Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy

Programmable Ultrasound Imaging Guided Theranostic Nanodroplet Destruction for Precision Therapy of Breast Cancer

On-demand drug release nanoplatform based on fluorinated aza-BODIPY for imaging-guided chemo-phototherapy

Protein-nanoparticle co-assembly supraparticles for drug delivery: Ultrahigh drug loading and colloidal stability, and instant and complete lysosomal drug release

Bovine serum albumin nanoparticles modified with multilayers and aptamers for pH-responsive and targeted anti-cancer drug delivery

Preparation and In Vitro Evaluation of a Multifunctional Iron Silicate@Liposome Nanohybrid for pH-Sensitive Doxorubicin Delivery and Photoacoustic Imaging

Targeted drug release from stable and safe ultrasound-sensitive nanocarriers